Latest Post

March 02, 2021

Understanding Risks of Coring and Fragmentation of Rubber Stoppers

When it comes to choosing the right container closure system, a significant amount of focus is directed at addressing issues that may be a risk to safety and efficacy of the parenteral drug before it is introduced to a patient. Examples are testing of container closure integrity (CCI) and drug stability. Prior to drug administration by a health care professional, the rubber stopper is pierced with a needle, at least once. Stopper puncture testing also needs to be considered, especially if the closure system will be used in a multi-dose application.
Bjoern Henze

Björn Henze

Manager, TCS. Commercial, EU

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    CZ Syringe and Vial with patient and nurse

    December 28, 2020

    Particles in Injectable Drugs

    Lynn Yao

    Lynn Yao

    Manager, Scientific Affairs, CN

    Contract Manufacturing

    May 29, 2020

    Contract Manufacturing: An Integrated Solutions Approach

    Shari Krusniak

    Shari Krusniak

    Director, Marketing, Contract Manufacturing & Integrated Solutions

    Load more